These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19911840)

  • 1. Peptidomics of prolyl endopeptidase in the central nervous system.
    Nolte WM; Tagore DM; Lane WS; Saghatelian A
    Biochemistry; 2009 Dec; 48(50):11971-81. PubMed ID: 19911840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.
    Kim YG; Lone AM; Nolte WM; Saghatelian A
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8523-7. PubMed ID: 22586115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo multiplex quantitative analysis of 3 forms of alpha melanocyte stimulating hormone in pituitary of prolyl endopeptidase deficient mice.
    Perroud B; Alvarado RJ; Espinal GM; Morado AR; Phinney BS; Warden CH
    Mol Brain; 2009 Jun; 2():14. PubMed ID: 19490636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomics of the prolyl peptidases.
    Lone AM; Nolte WM; Tinoco AD; Saghatelian A
    AAPS J; 2010 Dec; 12(4):483-91. PubMed ID: 20552307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform.
    Tinoco AD; Tagore DM; Saghatelian A
    J Am Chem Soc; 2010 Mar; 132(11):3819-30. PubMed ID: 20178363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
    J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney.
    Tenorio-Laranga J; Männistö PT; Storvik M; Van der Veken P; García-Horsman JA
    Biochimie; 2012 Sep; 94(9):1849-59. PubMed ID: 22546504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice.
    Kim JD; Toda C; D'Agostino G; Zeiss CJ; DiLeone RJ; Elsworth JD; Kibbey RG; Chan O; Harvey BK; Richie CT; Savolainen M; Myöhänen T; Jeong JK; Diano S
    Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11876-81. PubMed ID: 25071172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the proteolysis of bioactive peptides using a peptidomics approach.
    Kim YG; Lone AM; Saghatelian A
    Nat Protoc; 2013 Sep; 8(9):1730-42. PubMed ID: 23949379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
    Myöhänen TT; Tenorio-Laranga J; Jokinen B; Vázquez-Sánchez R; Moreno-Baylach MJ; García-Horsman JA; Männistö PT
    Br J Pharmacol; 2011 Aug; 163(8):1666-78. PubMed ID: 21133893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endo-acting proline-specific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides.
    Mäkinen PL; Mäkinen KK; Syed SA
    Infect Immun; 1994 Nov; 62(11):4938-47. PubMed ID: 7523301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-glycosylation in prolyl endoprotease from Aspergillus niger and evaluation of the enzyme for its possible application in proteomics.
    Sebela M; Rehulka P; Kábrt J; Rehulková H; Ozdian T; Raus M; Franc V; Chmelík J
    J Mass Spectrom; 2009 Nov; 44(11):1587-95. PubMed ID: 19757411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
    Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
    J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prolyl oligopeptidase by KYP-2047 fails to increase the extracellular neurotensin and substance P levels in rat striatum.
    Jalkanen AJ; Savolainen K; Forsberg MM
    Neurosci Lett; 2011 Sep; 502(2):107-11. PubMed ID: 21820035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal influence of prolyl endopeptidase on fat mass of adult progeny.
    Warden CH; Fisler JS; Espinal G; Graham J; Havel PJ; Perroud B
    Int J Obes (Lond); 2009 Sep; 33(9):1013-22. PubMed ID: 19564876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human serine endopeptidase, purified with respect to activity against a peptide with phosphoserine in the P1' position, is apparently identical with prolyl endopeptidase.
    Rosén J; Tomkinson B; Pettersson G; Zetterqvist O
    J Biol Chem; 1991 Feb; 266(6):3827-34. PubMed ID: 1995635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.
    Kumar N; Nakagawa P; Janic B; Romero CA; Worou ME; Monu SR; Peterson EL; Shaw J; Valeriote F; Ongeri EM; Niyitegeka JM; Rhaleb NE; Carretero OA
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1026-34. PubMed ID: 26962108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors.
    Lawandi J; Toumieux S; Seyer V; Campbell P; Thielges S; Juillerat-Jeanneret L; Moitessier N
    J Med Chem; 2009 Nov; 52(21):6672-84. PubMed ID: 19888757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target.
    Natunen TA; Gynther M; Rostalski H; Jaako K; Jalkanen AJ
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):40-49. PubMed ID: 29998529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the one-bead one-compound methodology for the design of prolyl oligopeptidase substrates.
    Comellas G; Kaczmarska Z; Tarragó T; Teixidó M; Giralt E
    PLoS One; 2009 Jul; 4(7):e6222. PubMed ID: 19593439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.